Accuracy of Published Advertisements in Three Distinguished Urology Journals in 2010 and 2011: A Critical Point of View

  • Mohaddeseh Mokhtarkhani Student research committee, Iranian Center for Evidence Based Medicine, Tabriz University of Sciences, Tabriz
  • Zahra Torabie Student research committee, Iranian Center for Evidence Based Medicine, Tabriz University of Sciences, Tabriz
  • Negar Taleschian Tabrizi
  • Sanaz Beig-Zali Student research committee, Iranian Center for Evidence Based Medicine, Tabriz University of Sciences, Tabriz
  • Sakineh Hajebrahimi Urology Department, Iranian Center for Evidence Based Medicine, Tabriz University of Sciences, Tabriz
Keywords: Advertisements, Urology journals, critical appraisal, evidence based medicine, EBM, Marketing, Editorship, Conflict of interest

Abstract

Purpose: It is vital to evaluate whether a restrictive procedure is applied for selecting advertisements and assess their adherence to the available evidences in medical journals. This descriptive study was carried out to determine validity of the published advertisements in three distinguished urology journals.

Methods: The advertised drugs and interventions in urology journals of three top urological associations, published in 2010 and 2011, were surveyed.

Results: The study of the articles retrieved a low number of systematic reviews(SRs); 27.77%, among which 54% were exactly relevant to the effectiveness of drugs and 22% were recommended by SRs as highest level of evidences. Based on the systematic review, the validity of the advertised drugs were not found to be high. Publishing the advertisements without sufficient supportive evidence could possibly lead to a degree of mistrust among the medical society.

Conclusion: This study suggested additional filtration in order to accept advertisements in scientfific journals.

References

Levy R. The role and value of pharmaceutical marketing. Arch Fam Med. 1994;3:327–32.

Wind Y. Pharmaceutical advertising.A business school perspective. Arch Fam Med. 1994;3:321–3.

Vlassov V, Mansfield P, Lexchin J, Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing?. West J Med. 2001 Jun;174(6):391-4.

Korenstein D, Keyhani S, Mendelson A, Ross JS. Adherence of pharmaceutical advertisements in medical jour nals to FDA guidelines and content for safe prescribing. PLoS One. 2011;6(8):e23336.

Othman N, Vitry A, Roughead EE. Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review. PLoS ONE. 2009;4(7):e6350.

Del Signore A, Murr AH, Lustig LR, Platt MP, Jalisi S, Pratt LW, Spiegel JH. Claim validity of print advertisements found in otolaryngology journals. Arch Otolaryngol Head Neck Surg. 2011;137(8): 746-750.

Santiago MG, Bucher HC, Nordmann AJ. Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland. BMC Med Inform Decis Mak. 2008 Dec 31;8:61.

Bhattacharyya T, Tornetta P 3rd, Healy WL, Einhorn TA. The Validity of Claims Made in Orthopaedic Print Advertisements. J Bone Joint Surg Am. 2003 Jul;85-A(7):1224-8.

Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, et al. Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review. PLoS Medicine. 2010;7(10):e1000352.

Published
2014-04-01
Section
Research Articles